GS
RMD icon

GAM Systematic’s ResMed RMD Stock Holding History

GAM Systematic’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,570
Closed -$113K – 625
2017
Q1 		$113K Sell
1,570
-1,218
-44% -$84.2K 0.02% 526
2016
Q4 		$173K Sell
2,788
-12,774
-82% -$782K 0.04% 493
2016
Q3 		$1.01M Sell
15,562
-393
-2% -$26.2K 0.21% 186
2016
Q2 		$1.01M Sell
15,955
-11,505
-42% -$678K 0.24% 144
2016
Q1 		$1.59M Buy
27,460
+11,686
+74% +$661K 0.42% 26
2015
Q4 		$847K Sell
15,774
-1,831
-10% -$103K 0.24% 158
2015
Q3 		$897K Sell
17,605
-2,443
-12% -$131K 0.21% 189
2015
Q2 		$1.13M Sell
20,048
-31,625
-61% -$2M 0.14% 241
2015
Q1 		$3.71M Buy
51,673
+25,256
+96% +$1.64M 0.51% 53
2014
Q4 		$1.48M Buy
+26,417
New +$1.38M 0.3% 141

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GAM Systematic's RMD Position: Q2 2017 in Review

GAM Systematic sold out of ResMed (RMD) in Q2 2017, closing a stake of 1,570 shares — an estimated $113K sold.

GAM Systematic first reported a position in RMD in Q4 2014 and held it in 10 quarters. The position peaked at $3.71M in Q1 2015. 339 funds tracked by Wall St. Rank hold RMD as of Q2 2017.

  • GAM Systematic reported no remaining ResMed position as of Q2 2017 after selling out during the quarter.
  • GAM Systematic sold 1,570 ResMed shares in Q2 2017, an estimated $113K.
  • GAM Systematic first reported a position in ResMed in Q4 2014 and held it in 10 quarters.
  • GAM Systematic's ResMed position peaked at $3.71M in Q1 2015.
  • 339 funds tracked by Wall St. Rank held ResMed as of Q2 2017.

Based on GAM Systematic's 13F filing for Q2 2017, filed 14 Aug 2017.